Stallergenes, S.A. Set to Begin Looking for U.S. Partner, Chief Executive Says

Bloomberg -- Stallergenes, Europe’s second- largest maker of allergy medicines, will start looking for a U.S. partner for its Oralair hay-fever treatment after meeting with U.S. regulators later this year.